Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study

EuroIntervention 2018;14:806-814 published online ahead of print May 2018. DOI: 10.4244/EIJ-D-18-00342

Johan Svanerud
Johan Svanerud1, MSc; Jung-Min Ahn2, MD; Allen Jeremias3,4, MD; Marcel van ‘t Veer5,6, MSc, PhD; Ankita Gore3,7, BS, MSc; Akiko Maehara3,7, MD; Aaron Crowley3, MA; Nico H.J. Pijls5,6, MD, PhD; Bernard De Bruyne8, MD, PhD; Nils P. Johnson9, MD, MS; Barry Hennigan10, MD; Stuart Watkins10, MD; Colin Berry10,11, MD, PhD; Keith G. Oldroyd10, MD; Seung-Jung Park2, MD, PhD; Ziad A. Ali3,4,7*, MD, DPhil
1. Coroventis Research AB, Uppsala, Sweden; 2. Asan Medical Center, Seoul, South Korea; 3. Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA; 4. St. Francis Hospital, Roslyn, NY, USA; 5. Catharina Hospital, Eindhoven, the Nethe

Aims: Randomised controlled trials have reported instantaneous wave-free ratio (iFR) to be non-inferior to fractional flow reserve (FFR) for major adverse cardiovascular events at one yea

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

fractional flow reserveinnovationother imaging modalities
Read next article
Five-year outcome of a randomised trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: the NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent trial (NEXT)

Latest news